Top Markets
Coin of the day
Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics, Inc.

OTLC
Classement en actions #30394
Oncotelic Therapeutics, Inc., an Agoura Hills, California-based clinical-stage... Oncotelic Therapeutics, Inc., an Agoura Hills, California-based clinical-stage biopharmaceutical company, specializes in developing therapeutics for rare oncological conditions. Its flagship therapeutic candidate, OT-101 – an antisense compound designed to inhibit TGF-ß2 – is currently undergoing Phase 3 clinical trials for both pancreatic cancer and glioblastoma. Beyond oncology, OT-101 is also being explored for its potential in treating various viral diseases, including severe acute respiratory syndrome (SARS) and coronaviruses. The company's pipeline further includes OXi4503, which is being advanced for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), and CA4P, intended for the treatment of advanced metastatic melanoma.
Prix de l'action
$0.03834
Dernière synchronisation: 2026-08-18
Capitalisation boursière
$17.01M
Changement (1 jour)
-4.15%
Changement (1 an)
-24.82%
Pays
US
Échange Oncotelic Therapeutics, Inc. (OTLC)

Catégorie

Le prix OTLC avec la capitalisation boursière de B
Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc.
OTLC
$0.03834
Capitalisation boursière de Oncotelic Therapeutics, Inc.(OTLC)
Capitalisation boursière: $17.01M
En August 2026, Oncotelic Therapeutics, Inc. a une capitalisation boursière de $17.01M. Cela fait de Oncotelic Therapeutics, Inc. la 30394th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Oncotelic Therapeutics, Inc. du 1993 au 2026
OTLC par rapport au top 5 des plus populaires stocks
Prix pour OTLC L’actif B La capitalisation boursière de B Résultats
Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc.
$11,962.10 $17.01M
$5.307T +31,199,952.11%
Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc.
$10,258.27 $17.01M
$4.551T +26,755,938.20%
Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc.
$9,364.77 $17.01M
$4.154T +24,425,489.39%
Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc.
$8,089.31 $17.01M
$3.589T +21,098,768.46%
Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc.
$6,304.66 $17.01M
$2.797T +16,443,967.68%